Close Menu

NEW YORK — OpGen reported after the close of the market Wednesday a 70 percent year-over-year increase in its third quarter revenues, beating its preliminary revenue announcement of a 54 percent increase.

For the three-month period ended Sept. 30, OpGen posted revenues of $1.1 million versus year-ago revenues of $648,220, beating Wall Street estimates of $1 million in revenues.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The European Medicines Agency recommends that a warning about the possibility of blood clots be added to the product information.

According to Agence France Presse, astronauts who are to arrive soon at the International Space Station are to study the effect of microgravity on brain organoids and more.

A new study finds that farmed fish have led to a decline in genetic diversity among Atlantic salmon, the Guardian reports.

In Cell this week: analysis of SARS-CoV-2 B.1.1.7 introductions to the US, increased horizontal gene transfer higher in gut microbiomes linked to industrialization, and more.